HomePatient StoriesFemale Pattern Hair Loss (Androgenetic Alopecia)
Women's Health · Hair Conditions

The Thinning Crown She Thought Was Stress
Adaeze's Hair Loss Has a Hormonal Root — and an Effective Treatment

Adaeze had been blaming stress for 2 years of crown thinning. Mascot Healthcare ran targeted blood tests, confirmed female pattern hair loss, corrected her ferritin deficiency, and started a treatment combination that halted her hair loss within 3 months.

Composite patient journey Names changed for privacy Mascot Healthcare, Akoka
📝 Note: This is a composite clinical narrative — constructed from multiple similar presentations at Mascot Healthcare. It accurately reflects the typical diagnostic experience. Patient details have been generalised for privacy.
The Patient
👩🏾‍🦱

Adaeze Okolie, 34

Architect. Presented with 2-year progressive thinning of hair at the crown and hairline — with widening central part. Trichoscopy showed miniaturised follicles. Ferritin mildly low. TSH normal. Testosterone normal. FPHL pattern confirmed.

Female Pattern Hair Loss (Androgenetic Alopecia)
How It Started

Two Years of Blaming the Wrong Cause

Adaeze had noticed the change in photographs from 2 years ago — the part at the crown was wider, the hair volume lower. She had attributed it to the stress of her architecture firm's busiest period. She started taking a biotin supplement (recommended by a colleague). She bought expensive shampoos. She stayed at least 3 months with each product "giving it time."

At Mascot Healthcare, the doctor performed a targeted clinical examination and trichoscopy — a handheld magnifying device showing the scalp and follicle pattern. The miniaturised, thin follicles in a Xmas-tree distribution at the crown were diagnostic of FPHL.

Blood tests added the key contribution: ferritin was only 12 ng/mL — significantly below the level needed for optimal hair follicle cycling. Low ferritin does not cause FPHL but dramatically worsens it.

Symptoms

Two Years of Progressive Crown Thinning

Female pattern hair loss (androgenetic alopecia) is the most common cause of hair loss in women — characterised by diffuse thinning at the crown with a widening central part, while the frontal hairline is largely preserved.

🔴
Crown and Central Parting Thinning

Visible thinning at the vertex and widening of the central hair part — more obvious on photographs comparing 2 years ago.

🔴
Increased Shedding

More hair on the pillow, shower drain, and hairbrush than before — but distributed loss, not patchy.

🔴
Preserved Frontal Hairline

The frontal hairline was intact — distinguishing female pattern from other hair loss types.

🔴
No Scalp Inflammation

No itching, redness, or scaling — excluding inflammatory alopecia.

🔴
Mildly Low Ferritin (12 ng/mL)

Serum ferritin 12 ng/mL — below the > 50 ng/mL threshold optimal for hair growth.

Before the Clinic

Two Years of Untargeted Management

Biotin 5 mg daily — no evidence of benefit for hair loss when biotin is not deficient.

Multiple premium shampoos (anti-hair loss formulations) — no clinical evidence of meaningful effect on FPHL.

Collagen powder supplements — no clinical evidence for FPHL.

Stress management — appropriate for general health; stress causes telogen effluvium (different condition), not androgenetic alopecia.

⚠️ Why this matters: Biotin supplementation for hair loss has no clinical evidence of benefit when biotin is not deficient — which is almost always the case. The widely promoted supplements (biotin, collagen, keratin) are not treatments for female pattern hair loss. Evidence-based treatments exist and are prescribed, not sold over the counter.
At Mascot Healthcare

Evidence-Based Treatment: Topical, Iron, and Oral Therapy

Iron supplementation, with vitamin C to aid absorption — target ferritin > 50 ng/mL.

A topical scalp treatment applied daily — the only topical treatment with strong clinical evidence for FPHL; slows shedding and stimulates regrowth over 3–6 months.

An oral medication that blocks the effect of androgens at the hair follicle — evidence-based for female pattern hair loss in women who tolerate it. Monthly blood pressure monitoring and electrolytes for first 3 months.

Diagnosis & Treatment

What Was Found — and What Happened Next

1

Diagnosis

Female Pattern Hair Loss (Androgenetic Alopecia) — trichoscopy-confirmed miniaturisation; concurrent ferritin deficiency (12 ng/mL)

2

Treatment

Iron supplementation; a daily topical scalp treatment; an oral anti-androgen medication; repeat ferritin and trichoscopy at 6 months

3

Follow-up

At 3 months: shedding significantly reduced; Adaeze reports hairbrush and pillow substantially clearer. At 6 months: ferritin 56 ng/mL; trichoscopy shows less miniaturisation; visible improvement at crown.

Outcome

At 6 months, shedding is controlled and crown density visibly improved on serial photographs. Adaeze continues the regimen with confidence.

What This Story Teaches Us

What Adaeze's Story Teaches Us

Female pattern hair loss is the most common hair loss diagnosis in women — and one of the most under-treated. Biotin and shampoo do not address the androgenetic mechanism. Proper medical treatment does.

Ferritin deficiency is a key modifiable factor that worsens hair loss. Any woman with hair loss should have ferritin measured alongside thyroid function and androgens.

Key takeaway

Hair thinning at the crown in women is most likely FPHL — not stress. The right treatment and blood tests make a real difference.

Thinning hair at the crown or widening hair part? Get a targeted hair loss assessment at Mascot Healthcare.

Book an appointment at Mascot Healthcare, Akoka — same-day slots often available, 4.9★ rated.

Service
Women's Health + Hair Assessment
Opening Hours
Mon–Sat 9AM–5PM
Location
Akoka, Lagos
💬 Book via WhatsApp 💬 WhatsApp Us
More Patient Stories

Other Journeys at Mascot Healthcare

💬 Book Now 💬 WhatsApp